In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
IPL 2022: Ian Bishop and Daniel Vettori angry with Sanju Samson, saying 'wasting...'
It is pleasant to watch Rajasthan Royals captain Sanju Samson bat, but it can also be disappointi
The cases of the global pandemic corona virus are increasing rapidly once again in Pakistan. It s
Israel-Hamas War: More than 195 people died in Israeli attacks on refugee camps, Hamas informed
The war between Israel and Hamas is continuously increasing. Many people have died so far during
Politics has intensified in the state after Bihar's Planning and Development Minister Bijendra Ya
This year on June 21, on World Yoga Day, Andhra Pradesh will create a new record with 2.5 lakh pe
Delhi MCD Election 2022: The date of the Delhi Municipal Corporation Election 2022 will be announ
Mumbai: Big action by GST department, man arrested for claiming fake refund of 27 crores
The Goods and Services Tax (GST) department of Maharashtra arrested a 26-year-old youth on Wednes
Senior Congress leader and former Prime Minister Manmohan Singh died on Thursday night, after whi
Aircraft made in China unable to fly, Nepal Airlines ready to sell for less money
Nepal Airlines is facing a huge loss. One reason for this is also the aircraft made in China. Now
Players preparing for the Olympics-2036 will get 50000 rupees every month, Amit Shah announced
Union Home Minister Amit Shah said on Friday that the government is giving Rs 50,000 per month to
